Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Alicja Sieminska"'
Autor:
Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Aleksander Kania, Katarzyna Lewandowska, Sebastian Majewski, Magdalena M. Martusewicz-Boros, Wojciech J. Piotrowski, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Witold Tomkowski, Beata Żołnowska, Rafał Krenke
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment. Objective: To provide real-wor
Externí odkaz:
https://doaj.org/article/f292078d43f34b2ea0136d89cf7f4dc6
Autor:
Alicja Sieminska
Publikováno v:
ResearcherID
Autor:
Alicja Sieminska
Publikováno v:
ResearcherID
Tobacco use leads in short time to nicotine dependence. Mechanisms of this process remain still not quite understood, of importance is also a question: When does nicotine dependence begin? The present review reports commonly used definition of nicoti
Autor:
Alicja Sieminska
Publikováno v:
ResearcherID
Numerous studies indicate genetical background of susceptibility to tobacco smoking. The current review presents new achievements and perspectives in searching for genes involved in tobacco smoking and dependence, which have been described in recent
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the w
Externí odkaz:
https://doaj.org/article/3701438ef5d04b65b221457cca370062
Publikováno v:
ResearcherID
In this review we presented a relation between cigarette smoking and lung cancer. We characterized molecular alterations resulting from carcinogens present in the cigarette smoke and presented the constitutive genetic profiles related to the increase
Autor:
Alicja Sieminska, Jassem-Bobowicz, Joanna M., Uherek, Maja, Wilanowski, Tomasz, Nowak, Radoslaw, Jassem, Ewa
Publikováno v:
Advances in Respiratory Medicine; Volume 77; Issue 4; Pages: 371-379
ResearcherID
ResearcherID
Introduction: The prevalence of smoking among medical students indicates that studying medicine is an insufficient protection from tobacco use. The aim of the study was an analysis of medical students’ attitudes towards smoking at the first and six
Autor:
Sebastian Majewski, Adam J. Białas, Małgorzata Buchczyk, Paweł Gomółka, Katarzyna Górska, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Rafał Krenke, Jan Kuś, Katarzyna Lewandowska, Magdalena M. Martusewicz-Boros, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Karolina Szewczyk, Małgorzata Tomczak, Witold Tomkowski, Elżbieta Wiatr, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD)
Externí odkaz:
https://doaj.org/article/819a0c653b2745e99c064475c66a7334
Autor:
Alicja Sieminska
Publikováno v:
ResearcherID
Conventional therapy of fibrogenic lung diseases, based mainly on the use of glucocorticoids or immunosuppressive, cytotoxic agents, does not usually protect before progression of disease and accumulation of the excess connective tissue in lungs. Thi